BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38148258)

  • 1. Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Am J Surg; 2024 Apr; 230():63-67. PubMed ID: 38148258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Surgery; 2024 Mar; 175(3):695-703. PubMed ID: 37863686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in long-term oncologic outcomes by type of cancer center accreditation: An analysis of a SEER-Medicare population with pancreatic cancer.
    Fong ZV; Chang DC; Hur C; Jin G; Tramontano A; Sell NM; Warshaw AL; Fernandez-Del Castillo C; Ferrone CR; Lillemoe KD; Qadan M
    Am J Surg; 2020 Jul; 220(1):29-34. PubMed ID: 32265013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Commission on Cancer Accreditation on Cancer Survival: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis.
    Ahmed A; Whittington J; Shafaee Z
    Ann Surg Oncol; 2024 Apr; 31(4):2286-2294. PubMed ID: 38093167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Access to Hospitals Most Ready to Achieve National Accreditation for Rectal Cancer Treatment.
    Antunez AG; Kanters AE; Regenbogen SE
    JAMA Surg; 2019 Jun; 154(6):516-523. PubMed ID: 30785616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Commission on Cancer Accreditation Status, Hospital Rurality and Hospital Size on Quality Measure Performance Rates.
    Schroeder MC; Gao X; Lizarraga I; Kahl AR; Charlton ME
    Ann Surg Oncol; 2022 Apr; 29(4):2527-2536. PubMed ID: 35067792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of care fragmentation on the outcomes of patients receiving neoadjuvant and adjuvant therapy for pancreatic adenocarcinoma.
    Brown ZJ; Labiner HE; Shen C; Ejaz A; Pawlik TM; Cloyd JM
    J Surg Oncol; 2022 Feb; 125(2):185-193. PubMed ID: 34599756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base.
    Bilimoria KY; Bentrem DJ; Stewart AK; Winchester DP; Ko CY
    J Clin Oncol; 2009 Sep; 27(25):4177-81. PubMed ID: 19636004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Breast Center Accreditation on Compliance with Breast Quality Performance Measures at Commission on Cancer-Accredited Centers.
    Miller ME; Bleicher RJ; Kaufman CS; Kurtzman SH; Chang C; Wang CH; Pollitt KA; Connolly J; Winchester DP; Yao KA
    Ann Surg Oncol; 2019 May; 26(5):1202-1211. PubMed ID: 30684159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does care fragmentation in patients with bladder cancer lead to worse outcomes?
    Riveros C; Chalfant V; Elshafei A; Bandyk M; Balaji KC
    Urol Oncol; 2023 Mar; 41(3):147.e7-147.e14. PubMed ID: 36631369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental market factors associated with electronic health record adoption among cancer hospitals.
    Tarver WL; Menachemi N
    Health Care Manage Rev; 2018; 43(4):303-314. PubMed ID: 28225447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between cancer center accreditation and performance on publicly reported quality measures.
    Merkow RP; Chung JW; Paruch JL; Bentrem DJ; Bilimoria KY
    Ann Surg; 2014 Jun; 259(6):1091-7. PubMed ID: 24509202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporting of Circumferential Resection Margin in Rectal Cancer Surgery.
    Manisundaram N; DiBrito SR; Hu CY; Kim Y; Wick E; Palis B; Peacock O; Chang GJ
    JAMA Surg; 2023 Nov; 158(11):1195-1202. PubMed ID: 37728906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cancer center accreditation on outcomes of patients undergoing resection for hepatocellular carcinoma: A SEER-Medicare analysis.
    Tsilimigras DI; Hyer JM; Diaz A; Moris D; Abbas A; Dillhoff M; Cloyd JM; Ejaz A; Beane JD; Tsung A; Pawlik TM
    Am J Surg; 2021 Sep; 222(3):570-576. PubMed ID: 33485619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fragmentation of cancer care on treatment use and survival in hepatocellular carcinoma.
    Hester CA; Karbhari N; Rich NE; Augustine M; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Singal AG; Yopp AC
    Cancer; 2019 Oct; 125(19):3428-3436. PubMed ID: 31299089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study.
    Vassantachart A; Marietta M; Mehta S; Lin E; Bian SX
    J Gastrointest Oncol; 2022 Dec; 13(6):2922-2937. PubMed ID: 36636091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragmented Care in the Treatment of Rectal Cancer and Time to Definitive Therapy.
    Abelson JS; Bauer PS; Barron J; Bommireddy A; Chapman WC; Schad C; Ohman K; Hunt S; Mutch M; Silviera M
    J Am Coll Surg; 2021 Jan; 232(1):27-33. PubMed ID: 33190785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is local excision an appropriate treatment modality in patients presenting with early-stage (cT1 N0 M0) rectal adenocarcinoma?
    Roat-Shumway S; Tonelli C; Singer M; Cohn T; Luchette FA; Abdelsattar Z; Baker MS
    Surgery; 2023 Mar; 173(3):665-673. PubMed ID: 36273975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study.
    Tang D; Rivard SJ; Weng W; Ramm CA; Cleary RK; Hendren S
    Dis Colon Rectum; 2023 May; 66(5):662-670. PubMed ID: 35195556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National postoperative and oncologic outcomes after pelvic exenteration for T4b rectal cancer.
    Konstantinidis IT; Lee B; Trisal V; Paz I; Melstrom K; Sentovich S; Lai L; Raoof M
    J Surg Oncol; 2020 Sep; 122(4):739-744. PubMed ID: 32516469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.